Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zinc therapy for sarcopenia in cirrhotic patients with hypozincemia
jRCTs051180222Completed
- Sponsor
- Nobelpharma Co., Ltd.
- Start
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of zinc acetate in Cirrhosis, Sarcopenia, zinc deficiency and 2 more (2 arms), sponsored by Nobelpharma Co., Ltd. Primary endpoint: Improvement of sarcopenia after 48 weeks. Started Feb 2019; status: completed.
02
Drugs
zinc acetate
03
Conditions
CirrhosisSarcopeniazinc deficiencyhepatic encephalopathy (HE)hyperammonemia
Beyond the preview
Go deeper on jRCTs051180222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051180222.